Mansfield, MA - March 1, 2005 - Axeda Systems Inc. (Nasdaq: XEDA), the world's leading provider of device relationship management (DRM) software and services, today announced that Tecan (SWX Swiss Exchange: TECN), a key player in the healthcare supply industry, has licensed the Axeda® DRM system for remote monitoring and proactive support of its FE500 liquid handling systems and laser scanner devices used in laboratory automation. The Axeda® DRM system is a remote management system that allows machine-to-machine communication via a secure Internet interface.
"Tecan supplies some of the world's leading pharmaceutical and diagnostic companies with a wide range of liquid handling solutions, detection devices and other proven automation-compatible instruments", said Joerg Borer, director global customer support at Tecan. "It is vital to our company and the reputation of our customers that we can maximize the operational running time of all our systems and devices. The Axeda DRM system will enable us to proactively monitor and service all of our deployed systems from anywhere in the world, reducing the number of field service visits and increasing the productivity of our customers."
In addition to real-time, remote monitoring and service, Tecan will use the Axeda DRM system to deliver remote software upgrades and patches, as well as to run remote desktop sharing sessions, and diagnostic programs for their customers.
"The real power of the Axeda DRM solution is that it allows organizations to have total transparency for their deployed assets without having to be on-site", said Robert M. Russell Jr. chairman and CEO of Axeda Systems. "With Axeda DRM, Tecan will gain greater intimacy with their customers and be able to provide even better service at a lower cost."
Tecan is a leading player in the health care supply industry that specializes in the development, production, and distribution of solutions enabling the discovery of pharmaceutical substances, as well as for genomics, proteomics, and diagnostics. Tecan clients are leading pharmaceutical and biotechnology companies, university research departments and diagnostic laboratories. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both North America and Europe and maintains a sales and service network in 52 countries. In 2003, Tecan achieved sales of CHF 311.6 million (USD 230.8 million; EUR 205.0 million). Registered shares of Tecan Group are traded on the SWX Swiss Exchange (TK: TECN / Reuters: TECZn.S / Valor : 1210019).
The Company's flagship product, the Axeda® DRM system helps manufacturing and service organizations increase revenue while lowering costs, by proactively monitoring and managing devices deployed at customer sites around the world. Axeda DRM is a highly scalable, field-proven, and comprehensive remote management solution that leverages its patented Firewall-Friendly™ technology to enable Machine-to-Machine (M2M) communication by utilizing the public Internet. Axeda customers include Global 2000 companies in many markets including Medical Instrument, Enterprise Technology, Office and Print Production Systems, and Industrial and Building Automation industries. Axeda has sales and service offices in the U.S. and Europe, and distribution partners worldwide. More information about Axeda is available at www.axeda.com.
Press Contact:
Erin Nolan Smith
Corporate
+1 508-718-6351
enolan@axeda.com
